๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Potentiation of carbon tetrachloride-induced hepatotoxicity and pneumotoxicity by pyridine

โœ Scribed by Day, Brian J. ;Carlson, Gary P. ;Denicola, Dennis B.


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
828 KB
Volume
8
Category
Article
ISSN
0887-2082

No coin nor oath required. For personal study only.

โœฆ Synopsis


Induction of P450IIE1 by pyridine was compared with that by ethanol, and the resulting potentiation of the pneumotoxicity and hepatotoxicity following carbon tetrachloride inhalation by pyridine was examined. Rats were treated with ethanol as either a 10% solution in the drinking water or as a daily bolus (3 ml/kg, ip) dose for 7 days or one bolus dose of pyridine (200 mg/kg, ip) and compared for P450IIE1 apoprotein content by immunoblot analysis. Ethanol in the drinking water and pyridine elevated both hepatic and pulmonary P450IIE1 apoprotein content, but bolus dose ethanol did not. The induction was greatest in the pyridine group. In the interaction study, rats were treated with pyridine (200 mg/kg, ip) and 12 hours later were exposed to CCl, (8000 ppm for 3 hours). Pulmonary injury and hepatic damage were assessed 24 hours later by bronchoalveolar lavage fluid (BALF) analysis [y-glutamyl transpeptidase (GGT), lactate dehydrogenase (LDH), and total protein] and serum sorbitol dehydrogenase (SDH) activity, respectively. Pyridine alone had no effect on BALF or SDH but enhanced GGT and LDH release into the BALF and SDH release into the serum when compared with CCl, exposure alone. Evaluation of the liver at the light microscopic level revealed characteristic CC1,-induced centrilobular necrosis which was potentiated by pyridine. No changes were observed in the lung by light microscopic evaluation. Pyridine induced pulmonary and hepatic microsomal apoprotein levels of cytochrome P450IIE1 two-and 2-to sixfold, respectively. Exposure to CCl, decreased hepatic but not pulmonary P4501IE1 levels. Induction of cytochrome P450IIE1 by pyridine increases the bioactivation of CC14 in both the liver and lung, leading to enhanced toxicity.


๐Ÿ“œ SIMILAR VOLUMES


Oral administration of diphenyl diseleni
โœ Cristina W. Nogueira; Lysandro Pinto Borges; Ana Cristina Guerra Souza ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 724 KB

Carbon tetrachloride (CCl 4 ) is a model for studying free radical-induced liver injury and screening hepato-protective drugs. Numerous studies have reported the involvement of oxidative stress in CCl 4 -induced liver damage and the hepato-protective effects mediated by different antioxidants. The p

Protection against carbon tetrachloride-
โœ K. P. Singh; A. K. Saxena; S. I. A. Zaidi; P. D. Dwivedi; S. P. Srivastava; P. K ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 369 KB

Protection from carbon tetrachloride ( CCIJ-induced hepatotoxicity by protein A was assessed histologically in rats. Carbon tetrachloride exposure produced swollen, vacuolated and necrotic cells in the centrilobular region of the hepatocyte in rats. Animals given protein A prior to and during CCl, t

Potentiation of carbon tetrachloride hep
โœ Britton, Robert S. ;Dolak, James A. ;Glende, Eric A. ;Recknagel, Richard O. ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 710 KB

Chlordecone greatly potentiates carbon tetrachloride (CC14) hepatotoxicity. In order to quantitate the degree of this potentiation, the effects of a range of doses of C C 4 on two microsomal enzymatic functions and liver enzyme release were examined in chlordecone-treated and control rats. Male Spra

Preventive effect of neutropenia on carb
โœ Yoshiji Ohta; Yoichiro Imai; Tatsuya Matsura; Akira Kitagawa; Kazuo Yamada ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 286 KB ๐Ÿ‘ 1 views

The preventive effect of neutropenia on carbon tetrachloride (CCl4)-induced hepatotoxicity was examined in rats. In rats treated once with CCl4 (1 ml kg(-1), i.p.), the serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), indices of liver cell damage, and the hepatic